Latest / Glaucoma, Vision & Longevity: Supplements & Science / A New Clue in Glaucoma: Leaky Blood Vessels May Damage Vision

Transcript

A New Clue in Glaucoma: Leaky Blood Vessels May Damage Vision · Glaucoma, Vision & Longevity: Supplements & Science

• 0:00
  SPEAKER_00: A new clue in glaucoma leaky blood vessels may damage vision.
• 0:04
  SPEAKER_00: Glaucoma is known as the silent thief of sight, slowly damaging the eye's nerve cells and causing vision loss.
• 0:11
  SPEAKER_00: Today, new research hints at surprising factors that could help protect vision or even restore it.
• 0:17
  SPEAKER_00: In April 2026, scientists reported several findings that may affect how we understand and treat glaucoma.
• 0:24
  SPEAKER_00: These include a study linking leaky tiny blood vessels to nerve damage, a tested drug, BOE10635, that helps keep nerve cells alive, and an artificial intelligence glaucoma earlier.
• 0:39
  SPEAKER_00: We'll explain each in plain language, note how close they are to helping patients, and give each finding an importance rating 1 to 10 for the big picture.
• 0:48
  SPEAKER_00: We'll also briefly mention a January 2026 study on a protective enzyme, GPX4, from Past News.
• 0:55
  SPEAKER_00: Leaky retinal blood vessels and glaucoma, importance?
• 0:58
  SPEAKER_00: 6 tenths.
• 0:59
  SPEAKER_00: One new idea is that damage to small retinal blood vessels might contribute to glaucoma.
• 1:05
  SPEAKER_00: Normally, the tiny blood vessels in the retina have tight barriers that keep fluid and cells from leaking into the delicate nerve layer.
• 1:13
  SPEAKER_00: But if this blood retinal barrier breaks down, harmful substances or immune cells could slip through and hurt the retinal ganglion cells, RGCs, the nerve cells lost in glaucoma.
• 1:24
  SPEAKER_00: A recent lab study found evidence for this effect.
• 1:27
  SPEAKER_00: In experiments on mice, researchers showed that removing certain immune cells, microglia, caused retinal vessels to become leaky after injury.
• 1:37
  SPEAKER_00: This leakiness allowed inflammation in the retina and actually reduced the ability of nerve cells to regrow their connections.
• 1:45
  SPEAKER_00: In other words, when the blood vessels leaked, nerve repair was worse.
• 1:50
  SPEAKER_00: The study highlighted that keeping the vessels sealed is important for nerve protection.
• 1:54
  SPEAKER_00: It's important to note this was early lab work in mice, looking at injury models, not human trials.
• 2:01
  SPEAKER_00: Still, it suggests that future glaucoma treatments might also aim to strengthen vessel barriers or control inflammation.
• 2:08
  SPEAKER_00: Despite being only in the lab so far, this finding is interesting because it adds a new clue to what makes glaucoma worse.
• 2:14
  SPEAKER_00: Rating about 6 tenths, it's an early discovery that opens new research ideas, but far from direct patient treatments.
• 2:23
  SPEAKER_00: A healthy blood retinal barrier has long been known as critical in diabetes and retinal diseases, and now it's being studied in glaucoma too.
• 2:32
  SPEAKER_00: Drug Whey 10635 protects nerve cells.
• 2:36
  SPEAKER_00: Importance 710.
• 2:38
  SPEAKER_00: Another April 2026 result came from a drug screen on retinal nerve cells.
• 2:42
  SPEAKER_00: Scientists tested a series of compounds on human-like retinal ganglion cells grown in the lab.
• 2:48
  SPEAKER_00: They found that Whey 110635, a drug originally studied in the brain, helped these glaucoma vulnerable nerve cells survive and function better.
• 2:58
  SPEAKER_00: Specifically, the drug boosted the cell's energy factories, mitochondria, and reduced their suicide signals.
• 3:05
  SPEAKER_00: The study, published of April 2026 in Communications Medicine, used both cell cultures and mouse models of optic nerve injury and glaucoma.
• 3:15
  SPEAKER_00: When mice were given Whey 1100635, their retinal ganglion cells were better protected after damage.
• 3:22
  SPEAKER_00: Importantly, treated mice kept more of their vision.
• 3:26
  SPEAKER_00: Tests showed their eyes could still send signals to the brain with much less loss.
• 3:31
  SPEAKER_00: In simple terms, Whey 10635 acted like a neuroprotector, helping the cells live through glaucoma stress.
• 3:39
  SPEAKER_00: This research is exciting because Whey 100635 is already a well-known drug.
• 3:44
  SPEAKER_00: It blocks a serotonin receptor called 5-HT1A and has been safely used in other studies.
• 3:50
  SPEAKER_00: However, the results are all from lab and animal studies.
• 3:54
  SPEAKER_00: We don't yet know if it will work in human glaucoma patients.
• 3:57
  SPEAKER_00: Clinical trials are needed, and that could take years.
• 4:00
  SPEAKER_00: Still, because the drug is already known, moving to human tests might be easier than a brand new chemical.
• 4:07
  SPEAKER_00: Rating 710, quite promising for neuroprotection, but still preclinical.
• 4:13
  SPEAKER_00: In plain terms, imagine an existing drug reloaded to protect the eye's nerves.
• 4:18
  SPEAKER_00: It's hopeful, but not ready yet to film a family trip or read again.
• 4:23
  SPEAKER_00: AI to predict glaucoma early.
• 4:25
  SPEAKER_00: Importance, 7 tenths.
• 4:27
  SPEAKER_00: Glaucoma often goes undetected until it's advanced.
• 4:30
  SPEAKER_00: New technology may change that.
• 4:32
  SPEAKER_00: Researchers have trained artificial intelligence AI systems to spot very early changes in the eye that predict who will develop glaucoma.
• 4:40
  SPEAKER_00: For example, one study developed a deep learning model using tens of thousands of retinal photos.
• 4:46
  SPEAKER_00: The AI learned patterns invisible to the human eye and could predict which eyes would turn into glaucoma within a few years.
• 4:54
  SPEAKER_00: The system achieved very high accuracy, area under the curve 4.90 in validation tests, meaning it correctly identifies most at-risk patients.
• 5:03
  SPEAKER_00: Remarkably, the researchers noted that their AI could even be used via a smartphone camera to screen patients in clinics or remotely.
• 5:12
  SPEAKER_00: What does this mean?
• 5:14
  SPEAKER_00: In the future, an eye doctor could snap a photo of your retina, and the AI would flag if you are at high risk for glaucoma before any vision loss occurs.
• 5:23
  SPEAKER_00: Early detection is valuable because treatments like eyedrops or laser could then be started sooner to prevent damage.
• 5:30
  SPEAKER_00: However, this AI is still in research stages.
• 5:34
  SPEAKER_00: One key study was published in 2022.
• 5:37
  SPEAKER_00: It needs more trials and approvals before it's a routine tool.
• 5:41
  SPEAKER_00: Rating 710, high potential to save vision through early action but still developing.
• 5:48
  SPEAKER_00: For patients right now, AI means hope for better screening in the future, but it doesn't change today's care yet.
• 5:54
  SPEAKER_00: It's similar to having a helpful assistant that catches risks early but isn't in all clinics yet.
• 6:00
  SPEAKER_00: Background GPX 4 and Nerve Protection, JAN 2026.
• 6:04
  SPEAKER_00: Before these April updates, another piece of news came in January 2026 about a protective enzyme called GPX-4, glutathione peroxidase 4.
• 6:14
  SPEAKER_00: Scientists found that in mouse glaucoma models, cells that naturally survive stress had higher levels of GPX-4, and giving mice extra GPX-4 helped their optic nerve regenerate.
• 6:25
  SPEAKER_00: In simpler terms, GPX-4 fights harmful oxidants, lipid peroxides, that can kill cells.
• 6:31
  SPEAKER_00: The study showed that boosting GPX-4 let many retinal ganglion cells and their axons survive after injury.
• 6:37
  SPEAKER_00: This suggests GPX-4-related drugs or antioxidants might someday be used to help protect or even repair the optic nerve.
• 6:46
  SPEAKER_00: But again, this is lab research in mice, published Jan 2nd in 2026.
• 6:51
  SPEAKER_00: It's an exciting clue, like discovering a shield in cells, but it's still a long road before any treatments for people.
• 6:58
  SPEAKER_00: Importance?
• 6:59
  SPEAKER_00: TORT 810s for future vision restoration research, but very preliminary.
• 7:04
  SPEAKER_00: What this means for patients right now.
• 7:06
  SPEAKER_00: Each of these updates gives hope, but it's important to be realistic today.
• 7:11
  SPEAKER_00: None of these findings is a new treatment you can get yet.
• 7:15
  SPEAKER_00: Blood vessel study, leaky vessels.
• 7:18
  SPEAKER_00: This adds to scientific understanding.
• 7:20
  SPEAKER_00: It won't change your eye care immediately, but in the future doctors may pay more attention to inflammation or blood flow in glaucoma.
• 7:28
  SPEAKER_00: Whey 10635 Drug, still in experiments.
• 7:32
  SPEAKER_00: Researchers are enthusiastic, but it's not prescribed for glaucoma patients now.
• 7:37
  SPEAKER_00: If further tests in animals and then humans are successful, it could become a supplement to pressure-lowering drops.
• 7:43
  SPEAKER_00: For now, stay on your current prescribed treatments.
• 7:47
  SPEAKER_00: AI early detection.
• 7:48
  SPEAKER_00: This could significantly help in the future by catching glaucoma even before obvious signs.
• 7:53
  SPEAKER_00: However, that technology needs more testing and FDA or other agency approval.
• 7:58
  SPEAKER_00: In the meantime, patients should continue regular eye exams.
• 8:02
  SPEAKER_00: AI on your phone isn't available at the optometrist yet, though it may come in a few years.
• 8:08
  SPEAKER_00: GPX4 research this is another lab discovery, not a human trial.
• 8:13
  SPEAKER_00: It suggests someday drugs targeting oxidation might help nerves, but that's still in the future.
• 8:18
  SPEAKER_00: Right now, antioxidants, like those in a healthy diet, are generally good, but there's no GPX-4 pill or gene therapy for glaucoma yet.
• 8:27
  SPEAKER_00: In summary, these studies mostly point toward future possibilities.
• 8:31
  SPEAKER_00: They are early stage.
• 8:32
  SPEAKER_00: Think of them as clues in a puzzle.
• 8:35
  SPEAKER_00: The only proven steps today remain lowering eye pressure as your doctor advises, drops, laser, or surgery, and monitoring your vision routinely.
• 8:44
  SPEAKER_00: Are we closer to regaining lost vision?
• 8:46
  SPEAKER_00: The ultimate question is: can these findings help restore the vision that glaucoma has already taken?
• 8:52
  SPEAKER_00: Unfortunately, we must be honest, not immediately.
• 8:55
  SPEAKER_00: All the latest research is on protecting or preserving the remaining nerve cells or on catching damage earlier.
• 9:02
  SPEAKER_00: None of it has yet shown actual vision return in patients.
• 9:05
  SPEAKER_00: Here's why.
• 9:07
  SPEAKER_00: The Weiwi 1106635 drug preserved function in mice, which is great, but human trials are needed.
• 9:14
  SPEAKER_00: Even then, protecting neurons usually means stopping further loss rather than fixing what is gone.
• 9:20
  SPEAKER_00: The AI tool helps with early detection, meaning treatments can begin sooner.
• 9:24
  SPEAKER_00: That helps keep vision from getting worse, but again, it doesn't restore lost sight.
• 9:30
  SPEAKER_00: The leaky vessel concept and GPX4 work are about understanding damage and potentially coaxing nerve regrowth in mice.
• 9:37
  SPEAKER_00: They suggest that maybe one day we could promote actual nerve repair.
• 9:41
  SPEAKER_00: But it's not here yet.
• 9:43
  SPEAKER_00: In other words, we are slowly building the science needed for true restoration, but it's likened to climbing a very tall mountain.
• 9:50
  SPEAKER_00: Each step, like these studies, is progress.
• 9:54
  SPEAKER_00: We can now hope that one day, these directions will lead to therapies that regenerate nerves or rewire the visual system.
• 10:02
  SPEAKER_00: For now, though, focus on preserving what vision you have through proven treatments and healthy habits.
• 10:08
  SPEAKER_00: Bottom line for patients April 2026 research brings interesting leads and reasons to be hopeful about the future.
• 10:16
  SPEAKER_00: But these updates do not change your immediate care.
• 10:20
  SPEAKER_00: Continue your current treatment plan to control eye pressure, follow your doctor's advice, and have regular checkups.
• 10:26
  SPEAKER_00: Think of this news as a sign that scientists are working 24-7 for new answers, a comforting boost for the long run, even if today's action items stay the same.
• 10:37
  SPEAKER_00: All links to sources are available in the text version of this article.
• 10:41
  SPEAKER_00: You can find the full article at Visualfieldtest.com.
• 10:45
  SPEAKER_00: Thanks for listening.
• 10:46
  SPEAKER_00: To check your visual field, click the link at the bottom of this article or visit visualfieldtest.com.